ARCHIVES

BRMP Investigators Find New Lung Tumor Antigen, Seek Developers

This article is from The Cancer Letter archive.

Vol. 08 No. 02 | January 8, 1982

Download PDF Visit The Full Archive

Related Articles

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles

November 4, 1983

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

December 14, 2001